MeiraGTx Holdings plc Ordinary Shares

MGTXNASDAQUSD
9.66 USD
0.48 (5.19%)🟢LIVE (AS OF 02:54 PM EDT)
🟢Market: OPEN
Open?$9.21
High?$9.88
Low?$9.12
Prev. Close?$9.18
Volume?864.8K
Avg. Volume?540.7K
VWAP?$9.66
Rel. Volume?1.60x
Bid / Ask
Bid?$9.68 × 100
Ask?$9.70 × 100
Spread?$0.02
Midpoint?$9.69
Valuation & Ratios
Market Cap?747.7M
Shares Out?81.4M
Float?55.5M
Float %?70.9%
P/E Ratio?N/A
P/B Ratio?-129.07
EPS?-$1.40
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?0.75Weak
Quick Ratio?0.75Weak
Cash Ratio?0.54Adequate
Debt/Equity?-12.86Low
ValuationFAIRLY VALUED
Score
67/100
P/E?
N/A
P/B?
-129.07CHEAP
P/S?
9.19HIGH
P/FCF?
N/A
EV/EBITDA?
-8.1CHEAP
EV/Sales?
9.29HIGH
Returns & Efficiency
ROE?
1,971.4%STRONG
ROA?
-46.7%WEAK
Cash Flow & Enterprise
FCF?$-50185000
Enterprise Value?$756.2M
Related Companies
Loading...
News
Profile
MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.
Employees
403
Market Cap
747.7M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Listed
2018-06-08
Address
655 THIRD AVENUE
NEW YORK, NY 10017
Phone: 646-860-7985